In ₹ Crore except Per Share 12 Months Ending | Q4 FY25 31/03/2025 | Q1 FY26 30/06/2025 | Q2 FY26 30/09/2025 | Q3 FY26 31/12/2025 | Q4 FY26 31/03/2026 | Q1 FY27 30/06/2026 | |
|---|---|---|---|---|---|---|---|
| Total Income | 2,43,692.7 | 2,24,950.2 | 2,41,536.4 | 2,36,094.3 | 2,79,197.8 | 2,40,167.8 | |
| Expenses | |||||||
| Total Expenses | 2,23,422.2 | 2,12,729.9 | 2,30,951.0 | 2,22,825.7 | 2,54,233.3 | 2,26,207.8 | |
| Profit | |||||||
| + Current Tax | 3,422.0 | 1,616.3 | 1,421.9 | 1,982.1 | -9,068.7 | 1,626.0 | |
| Revenue Detail — as filed | |||||||
| + Investment Income | 1,774.5 | 1,801.1 | 2,066.0 | 2,261.8 | 2,465.9 | 2,557.2 | |
| + Income from Investments (net) | 93,442.8 | 1,03,252.0 | 1,12,528.3 | 1,07,704.3 | 1,09,210.7 | 1,09,685.3 | |
| Expense Detail — as filed | |||||||
| + Administration Expenses | 2,003.7 | 1,319.6 | 1,264.8 | 3,051.3 | 3,021.6 | 1,867.1 | |
| + Advertisement & Publicity | 217.7 | 74.5 | 172.3 | 141.7 | 297.0 | 93.5 | |
| + Employee Remuneration & Welfare | 5,942.6 | 5,685.8 | 7,522.2 | 5,839.2 | 8,891.2 | 6,048.3 | |
| + Commission | 7,736.0 | 4,977.3 | 5,806.0 | 6,039.5 | 7,741.0 | 5,061.6 | |
| + Commission (net) | 7,735.5 | 4,975.3 | 5,807.4 | 6,039.5 | 7,733.4 | 5,061.6 | |
| + Provision — Diminution in Investments | -414.6 | -362.4 | -250.2 | -245.8 | 75.2 | -1.8 | |
| + Provision — Doubtful Debts & Write-offs | -1,014.1 | -26.1 | -156.7 | -84.6 | -544.0 | -565.7 | |
| + Provision — Doubtful Debts incl. Write-off | 1.3 | -0.4 | -0.5 | 0.1 | -0.1 | -0.1 | |
| Profit Build-up — Alternate / Pre-Ind-AS Tags | |||||||
| Profit / (Loss) before Tax | 19,045.7 | 10,985.8 | 10,201.7 | 12,879.7 | 23,456.7 | 13,686.4 | |
| + Current Taxes | 7.1 | 28.7 | 103.2 | -50.7 | -10.5 | 102.1 | |
| + Provision for Tax | 3,422.0 | 1,616.3 | 1,421.9 | 1,982.1 | -9,068.7 | 1,626.0 | |
| + Provisions for Taxes | 7.1 | 28.7 | 103.2 | -50.7 | -10.5 | 102.1 | |
| PAT before Extraordinary Items | 19,038.7 | 10,957.1 | 10,098.5 | 12,930.4 | 23,467.2 | 13,584.3 | |
| PAT after Extraordinary Items | 19,038.7 | 10,957.1 | 10,098.5 | 12,930.4 | 23,467.2 | 13,584.3 | |
| Profit Carried to Balance Sheet | 1,20,216.5 | 1,31,130.6 | 1,33,620.8 | 1,46,547.9 | 1,70,003.1 | 1,77,262.1 | |
| Per Share — as-filed variants | |||||||
| Basic & Diluted EPS before Extraordinary (not annualised) | 30.10 | 17.32 | 15.97 | 20.44 | 37.10 | 10.74 | |
| Basic & Diluted EPS after Extraordinary (not annualised) | 30.10 | 17.32 | 15.97 | 20.44 | 37.10 | 10.74 | |
| Appropriations & Transfers | |||||||
| Reserves & Surplus excl. Revaluation Reserve | 1,21,193.9 | 1,32,156.1 | 1,34,730.4 | 1,47,683.1 | 1,71,230.9 | 1,78,490.0 | |
| Insurance — Revenue Account (Policyholders') | |||||||
| + Gross Premium Income | 1,48,222.0 | 1,19,753.9 | 1,27,087.3 | 1,26,176.6 | 1,65,360.8 | 1,27,796.1 | |
| + Net Premium Income | 1,47,917.2 | 1,19,618.4 | 1,26,930.0 | 1,25,988.2 | 1,65,067.2 | 1,27,623.2 | |
| + First-year Premium | 11,103.0 | 7,566.0 | 10,884.5 | 10,648.5 | 13,009.0 | 9,257.5 | |
| + Renewal Premium | 79,425.0 | 60,179.4 | 65,320.5 | 69,617.4 | 82,233.2 | 62,129.3 | |
| + Single Premium | 57,694.1 | 52,008.5 | 50,882.3 | 45,910.8 | 70,118.6 | 56,409.4 | |
| + Commission — First-year Premium | 2,804.2 | 1,754.1 | 2,203.7 | 2,271.9 | 3,138.9 | 1,920.1 | |
| + Commission — Renewal Premium | 4,665.1 | 3,098.5 | 3,398.3 | 3,578.3 | 4,165.5 | 3,007.0 | |
| + Commission — Single Premium | 266.6 | 124.8 | 204.0 | 189.3 | 436.7 | 134.5 | |
| + Expenses of Management | 16,526.2 | 12,558.3 | 15,308.4 | 15,643.5 | 20,698.7 | 13,604.5 | |
| + Operating Expenses — Insurance Business | 8,790.7 | 7,583.0 | 9,501.0 | 9,603.9 | 12,965.3 | 8,543.0 | |
| + Expenses — Non-insurance | 52.1 | 539.9 | 70.6 | 20.9 | 530.0 | 517.8 | |
| + Benefits Paid (net) | 1,42,764.9 | 97,550.9 | 1,06,976.7 | 1,13,818.8 | 1,80,168.5 | 1,21,911.5 | |
| + Change in Actuarial Liability | 62,051.9 | 1,01,349.4 | 1,07,569.1 | 91,688.2 | 62,903.8 | 89,633.2 | |
| + Bonus Allocated to Policyholders | 56,235.9 | 0.0 | 0.0 | 102.9 | 59,622.7 | 0.0 | |
| + Interim Bonus Paid | 546.5 | 875.3 | 1,137.5 | 1,873.5 | 4,470.4 | 928.4 | |
| + GST on Linked Charges | 85.9 | 43.6 | 81.8 | 23.5 | -0.2 | 0.0 | |
| Surplus in the Revenue Account | 20,270.5 | 12,220.3 | 10,585.4 | 13,268.6 | 24,964.5 | 13,960.1 | |
| Net Surplus / (Deficit) | 20,270.5 | 12,220.3 | 10,585.4 | 13,268.6 | 24,964.5 | 13,960.1 | |
| + Funds for Future Appropriation | 1,856.4 | 1,482.8 | 1,131.1 | 1,596.1 | 2,771.7 | 1,750.9 | |
| + Policyholders' Liabilities to Shareholders' Fund | 43.0 | 40.8 | 40.2 | 37.7 | 32.4 | 30.8 | |
| Insurance — Shareholders' Account | |||||||
| + Income under Shareholders' Account | 1,818.0 | 1,846.0 | 2,114.1 | 2,310.7 | 2,515.2 | 2,608.8 | |
| + Shareholders' Account Income | 20,232.2 | 12,583.5 | 11,568.5 | 13,983.2 | 24,708.0 | 14,818.0 | |
| + Shareholders' Account Expenses | 1,186.4 | 1,597.8 | 1,366.8 | 1,103.5 | 1,251.3 | 1,131.6 | |
| + Shareholders' Provision — Diminution in Investments | -7.9 | -1.1 | -19.8 | -2.6 | 0.2 | 2.9 | |
| + Transfer from Policyholders' Account | 18,414.1 | 10,737.5 | 9,454.3 | 11,672.5 | 22,192.8 | 12,209.2 | |
| + Transfer of Funds to Policyholders' Account | 1,140.8 | 1,059.4 | 1,316.5 | 1,085.0 | 721.2 | 610.9 | |
| + Transferred to Shareholders' Account | 18,414.1 | 10,737.5 | 9,454.3 | 11,672.5 | 22,192.8 | 12,209.2 | |
| Shareholders' Fund — with Unrealised Gains | 6.3 | 10.1 | 6.5 | 10.1 | -1.3 | 9.0 | |
| Shareholders' Fund — without Unrealised Gains | 6.9 | 6.1 | 6.5 | 6.7 | 6.9 | 6.2 | |
| Insurance — Fund NPAs | |||||||
| + Gross NPAs — Shareholders' Fund | 56.5 | 56.5 | 0.0 | 0.0 | 0.0 | 0.0 | |
| + Gross NPAs — Linked Non-participating | 114.2 | 114.2 | 114.2 | 35.8 | 35.8 | 35.8 | |
| + Gross NPA % — Linked Non-participating | 0.30 | 0.30 | 0.25 | 0.10 | 0.08 | 0.08 | |
| + Linked Non-participating — with Unrealised Gains | 0.0 | 0.0 | -0.0 | 0.0 | -0.0 | 0.0 | |
| + Linked Non-participating — without Unrealised Gains | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| + Gross NPAs — Non-linked Participating | 8,328.7 | 8,322.2 | 7,934.8 | 7,745.7 | 7,169.4 | 7,132.2 | |
| + Net NPAs — Non-linked Participating | 5.5 | 3.6 | 3.9 | 4.2 | 4.3 | 4.9 | |
| + Gross NPA % — Non-linked Participating | 0.02 | 0.02 | 0.02 | 0.02 | 0.01 | 0.01 | |
| + Non-linked Participating — with Unrealised Gains | 0.0 | 0.0 | 0.0 | 0.0 | -0.0 | 0.0 | |
| + Non-linked Participating — without Unrealised Gains | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| + Non-linked Non-participating — with Unrealised Gains | 0.0 | 0.0 | -0.0 | 0.0 | -0.0 | 0.0 | |
| + Non-linked Non-participating — without Unrealised Gains | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Insurance — IRDAI Ratios (as filed, not percentages) | |||||||
| Solvency Ratio | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | |
| Conservation Ratio | 0.87 | 0.94 | 0.89 | 0.96 | 0.91 | 0.91 | |
| Expenses of Management Ratio | 0.11 | 0.10 | 0.12 | 0.12 | 0.13 | 0.11 | |
| Persistency — 13th Month | 0.69 | 0.71 | 0.68 | 0.69 | 0.68 | 0.70 | |
| Persistency — 25th Month | 0.65 | 0.66 | 0.63 | 0.64 | 0.63 | 0.66 | |
| Persistency — 37th Month | 0.60 | 0.64 | 0.61 | 0.61 | 0.62 | 0.63 | |
| Persistency — 49th Month | 0.56 | 0.63 | 0.58 | 0.59 | 0.57 | 0.62 | |
| Persistency — 61st Month | 0.59 | 0.58 | 0.55 | 0.55 | 0.54 | 0.61 | |
| Regulatory Disclosures — filed alongside, not part of the P&L | |||||||
| Investor Complaints — During the Period | 1.00 | 2.00 | 23.00 | -21.00 | -2.00 | 11.00 | |
| Investor Complaints — Received | 130.00 | 122.00 | 488.00 | 171.00 | 141.00 | 323.00 | |
| Investor Complaints — Disposed | 129.00 | 120.00 | 465.00 | 192.00 | 143.00 | 312.00 | |
| Other Filed Concepts — mapped but not yet placed in the schedule | |||||||
| Other Operating Expenses | 626.7 | 503.0 | 541.7 | 571.8 | 755.5 | 534.1 | |